Prescription addiction is a national problem in the United States. Although there has been some public acknowledgement of its existence in general terms recently, the real scope of how deep and pervasive prescription addiction is in this country is still mostly hidden from public view.

Because of this, Big Pharma and the medical profession still pushes the two classes of drugs – central nervous system (CNS) depressants (“downers”) and central nervous system (CNS) stimulants (“uppers”) – at the core of prescription addiction insistently and without restraint. Continue reading →